$2.39 Billion is the total value of Artal Group S.A.'s 139 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 18.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARGX | Buy | ARGENX SEsponsored adr | $185,245,000 | +5.8% | 587,500 | +17.5% | 7.76% | +63.2% |
| WW | WW INTL INC | $151,591,000 | -36.6% | 14,818,300 | 0.0% | 6.35% | -2.1% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $148,763,000 | -47.0% | 71,178,364 | 0.0% | 6.23% | -18.2% | |
| BGNE | Sell | BEIGENE LTDsponsored adr | $125,419,000 | -31.4% | 665,000 | -1.5% | 5.25% | +5.8% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $110,997,000 | -46.0% | 1,350,000 | -3.6% | 4.65% | -16.6% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $106,139,000 | -3.7% | 650,000 | 0.0% | 4.44% | +48.6% | |
| SGEN | Buy | SEAGEN INC | $93,633,000 | +21.1% | 650,000 | +30.0% | 3.92% | +86.9% |
| FATE | Buy | FATE THERAPEUTICS INC | $77,540,000 | -26.4% | 2,000,000 | +11.1% | 3.25% | +13.6% |
| SEER | SEER INC | $72,390,000 | -33.2% | 4,750,000 | 0.0% | 3.03% | +3.1% | |
| MORF | Buy | MORPHIC HLDG INC | $66,248,000 | -11.8% | 1,650,000 | +4.1% | 2.77% | +36.1% |
| BLU | BELLUS HEALTH INC NEW | $58,480,000 | -14.5% | 8,500,000 | 0.0% | 2.45% | +31.8% | |
| IGMS | Buy | IGM BIOSCIENCES INC | $53,460,000 | +21.5% | 2,000,000 | +33.3% | 2.24% | +87.4% |
| CERE | CEREVEL THERAPEUTICS HLDNG I | $52,515,000 | +8.0% | 1,500,000 | 0.0% | 2.20% | +66.6% | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $47,974,000 | -8.9% | 850,000 | 0.0% | 2.01% | +40.5% | |
| KYMR | KYMERA THERAPEUTICS INC | $42,320,000 | -33.3% | 1,000,000 | 0.0% | 1.77% | +2.8% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $37,880,000 | -45.3% | 4,000,000 | -33.3% | 1.59% | -15.6% |
| CYTK | CYTOKINETICS INC | $36,810,000 | -19.2% | 1,000,000 | 0.0% | 1.54% | +24.6% | |
| KRYS | Sell | KRYSTAL BIOTECH INC | $33,270,000 | -32.1% | 500,000 | -28.6% | 1.39% | +4.8% |
| SRRK | SCHOLAR ROCK HLDG CORP | $31,581,000 | -48.1% | 2,450,000 | 0.0% | 1.32% | -19.9% | |
| ERASCA INC | $27,281,000 | -44.8% | 3,172,221 | 0.0% | 1.14% | -14.8% | ||
| FHTX | FOGHORN THERAPEUTICS INC | $26,207,000 | -33.4% | 1,720,720 | 0.0% | 1.10% | +2.7% | |
| SAGE | Sell | SAGE THERAPEUTICS INC | $24,825,000 | -41.6% | 750,000 | -25.0% | 1.04% | -10.0% |
| SDGR | SCHRODINGER INC | $23,884,000 | -2.0% | 700,000 | 0.0% | 1.00% | +51.1% | |
| RLAY | Sell | RELAY THERAPEUTICS INC | $20,951,000 | -9.0% | 700,000 | -6.7% | 0.88% | +40.3% |
| GBIO | GENERATION BIO CO | $20,656,000 | +3.7% | 2,814,191 | 0.0% | 0.86% | +59.9% | |
| GOSS | GOSSAMER BIO INC | $20,476,000 | -23.3% | 2,358,968 | 0.0% | 0.86% | +18.4% | |
| RUBY | RUBIUS THERAPEUTICS INC | $20,396,000 | -43.1% | 3,701,580 | 0.0% | 0.85% | -12.1% | |
| TALS | TALARIS THERAPEUTICS INC | $20,312,000 | -35.6% | 2,064,262 | 0.0% | 0.85% | -0.7% | |
| NTLA | INTELLIA THERAPEUTICS INC | $19,984,000 | -38.5% | 275,000 | 0.0% | 0.84% | -5.1% | |
| DNLI | DENALI THERAPEUTICS INC | $19,302,000 | -27.9% | 600,000 | 0.0% | 0.81% | +11.3% | |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $18,946,000 | -55.7% | 800,100 | -36.0% | 0.79% | -31.6% |
| EVTCY | EVOTEC AGsponsored ads | $17,391,000 | -36.3% | 1,149,425 | 0.0% | 0.73% | -1.8% | |
| KURA | KURA ONCOLOGY INC | $16,884,000 | +14.9% | 1,050,000 | 0.0% | 0.71% | +77.2% | |
| EQRX INC | $16,520,000 | -39.4% | 4,000,000 | 0.0% | 0.69% | -6.5% | ||
| ALVR | ALLOVIR INC | $15,683,000 | -47.8% | 2,323,371 | 0.0% | 0.66% | -19.5% | |
| REPL | REPLIMUNE GROUP INC | $15,282,000 | -37.3% | 900,000 | 0.0% | 0.64% | -3.3% | |
| INTC | INTEL CORPcall | $14,856,000 | -3.8% | 300,000 | 0.0% | 0.62% | +48.4% | |
| OMEGA THERAPEUTICS INC | $14,187,000 | -44.9% | 2,273,530 | 0.0% | 0.59% | -15.0% | ||
| APTX | APTINYX INC | $13,884,000 | -15.0% | 6,116,493 | 0.0% | 0.58% | +31.2% | |
| IMAB | I MABsponsored ads | $13,804,000 | -65.7% | 850,000 | 0.0% | 0.58% | -47.1% | |
| AGEN | Sell | AGENUS INC | $13,530,000 | -35.4% | 5,500,000 | -15.4% | 0.57% | -0.4% |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $12,872,000 | -49.2% | 400,000 | -26.5% | 0.54% | -21.5% |
| AUPH | AURINIA PHARMACEUTICALS INC | $12,380,000 | -45.9% | 1,000,000 | 0.0% | 0.52% | -16.6% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $12,252,000 | -48.2% | 1,200,000 | 0.0% | 0.51% | -20.0% | |
| KRON | KRONOS BIO INC | $11,156,000 | -46.8% | 1,542,954 | 0.0% | 0.47% | -17.9% | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $10,162,000 | – | 200,000 | +100.0% | 0.42% | – |
| RPTX | REPARE THERAPEUTICS INC | $9,968,000 | -32.5% | 700,000 | 0.0% | 0.42% | +4.0% | |
| IKNA | IKENA ONCOLOGY INC | $9,452,000 | -51.4% | 1,549,513 | 0.0% | 0.40% | -24.9% | |
| MARINUS PHARMACEUTICALS INC | $9,350,000 | -21.3% | 1,000,000 | 0.0% | 0.39% | +21.4% | ||
| FMTX | FORMA THERAPEUTICS HLDGS INC | $9,300,000 | -34.6% | 1,000,000 | 0.0% | 0.39% | +0.8% | |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $9,290,000 | -60.7% | 1,000,000 | -33.3% | 0.39% | -39.3% |
| VERV | VERVE THERAPEUTICS INC | $9,128,000 | -38.1% | 400,000 | 0.0% | 0.38% | -4.5% | |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $8,867,000 | -54.4% | 2,152,291 | 0.0% | 0.37% | -29.6% | |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $8,778,000 | +17.6% | 2,200,000 | +83.3% | 0.37% | +81.3% |
| ALXO | ALX ONCOLOGY HLDGS INC | $8,450,000 | -21.4% | 500,000 | 0.0% | 0.35% | +21.2% | |
| SAGE | SAGE THERAPEUTICS INCcall | $8,275,000 | -22.2% | 250,000 | 0.0% | 0.35% | +19.7% | |
| EXSCIENTIA PLCads | $7,920,000 | -27.1% | 550,000 | 0.0% | 0.33% | +12.5% | ||
| IMUX | IMMUNIC INC | $7,910,000 | +18.1% | 700,000 | 0.0% | 0.33% | +81.9% | |
| New | VIGIL NEUROSCIENCE INC | $7,882,000 | – | 1,121,191 | +100.0% | 0.33% | – | |
| OVID | OVID THERAPEUTICS INC | $7,850,000 | -2.2% | 2,500,000 | 0.0% | 0.33% | +50.9% | |
| SQZ | SQZ BIOTECHNOLOGIES CO | $7,726,000 | -46.1% | 1,606,309 | 0.0% | 0.32% | -17.0% | |
| TGTX | TG THERAPEUTICS INC | $7,608,000 | -49.9% | 800,000 | 0.0% | 0.32% | -22.6% | |
| OTLY | OATLY GROUP ABsponsored ads | $7,515,000 | -37.1% | 1,500,000 | 0.0% | 0.32% | -2.8% | |
| NBTX | NANOBIOTIX SAsponsored ads | $7,440,000 | -8.1% | 1,000,000 | 0.0% | 0.31% | +41.4% | |
| OMEG | OMEGA ALPHA SPACcl a | $7,365,000 | +0.5% | 750,000 | 0.0% | 0.31% | +54.8% | |
| LPTX | LEAP THERAPEUTICS INC | $7,000,000 | -46.0% | 4,000,000 | 0.0% | 0.29% | -16.8% | |
| SE | New | SEA LTDsponsored ads | $6,888,000 | – | 57,500 | +100.0% | 0.29% | – |
| TSHA | TAYSHA GENE THERAPIES INC | $6,787,000 | -44.0% | 1,040,882 | 0.0% | 0.28% | -13.7% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $6,631,000 | -41.3% | 2,255,375 | 0.0% | 0.28% | -9.4% | |
| DSGN | DESIGN THERAPEUTICS INC | $6,460,000 | -24.6% | 400,000 | 0.0% | 0.27% | +16.4% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $5,980,000 | -12.7% | 200,000 | 0.0% | 0.25% | +34.4% | |
| FUSN | FUSION PHARMACEUTICALS INC | $5,828,000 | +86.3% | 750,000 | 0.0% | 0.24% | +187.1% | |
| CFRX | CONTRAFECT CORP | $5,475,000 | +38.8% | 1,500,000 | 0.0% | 0.23% | +114.0% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $5,319,000 | -35.2% | 593,030 | 0.0% | 0.22% | 0.0% | |
| STOK | STOKE THERAPEUTICS INC | $5,263,000 | -12.3% | 250,000 | 0.0% | 0.22% | +35.0% | |
| DYN | DYNE THERAPEUTICS INC | $5,061,000 | -18.9% | 525,000 | 0.0% | 0.21% | +25.4% | |
| NEXI | NEXIMMUNE INC | $5,052,000 | -8.7% | 1,200,000 | 0.0% | 0.21% | +41.3% | |
| HARP | HARPOON THERAPEUTICS INC | $4,970,000 | -34.2% | 1,000,000 | 0.0% | 0.21% | +1.5% | |
| DYNS | DYNAMICS SPECIAL PURPOSE COR | $4,935,000 | +0.1% | 500,000 | 0.0% | 0.21% | +54.5% | |
| SELB | SELECTA BIOSCIENCES INC | $4,920,000 | -62.3% | 4,000,000 | 0.0% | 0.21% | -41.8% | |
| TIL | INSTIL BIO INC | $4,838,000 | -37.2% | 450,000 | 0.0% | 0.20% | -2.9% | |
| YMAB | Y-MABS THERAPEUTICS INC | $4,752,000 | -26.7% | 400,000 | 0.0% | 0.20% | +13.1% | |
| RNA | AVIDITY BIOSCIENCES INC | $4,618,000 | -22.3% | 250,000 | 0.0% | 0.19% | +19.9% | |
| New | ADAGIO THERAPEUTICS INC | $4,560,000 | – | 1,000,000 | +100.0% | 0.19% | – | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $4,561,000 | -48.0% | 1,646,517 | 0.0% | 0.19% | -19.7% | |
| SPRO | SPERO THERAPEUTICS INC | $4,350,000 | -45.7% | 500,000 | 0.0% | 0.18% | -16.1% | |
| HOOK | Buy | HOOKIPA PHARMA INC | $4,217,000 | +201.9% | 1,849,616 | +208.5% | 0.18% | +365.8% |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $4,165,000 | -57.4% | 3,500,000 | +16.7% | 0.17% | -34.3% |
| MIRION TECHNOLOGIES INC | $4,035,000 | -22.9% | 500,000 | 0.0% | 0.17% | +19.0% | ||
| ACIU | AC IMMUNE SA | $4,000,000 | -19.2% | 1,000,000 | 0.0% | 0.17% | +24.6% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $3,930,000 | -25.6% | 3,000,000 | 0.0% | 0.16% | +15.4% | |
| PORTAGE FINTECH ACQUISITN CO | $3,773,000 | -0.2% | 380,000 | 0.0% | 0.16% | +53.4% | ||
| SLDB | SOLID BIOSCIENCES INC | $3,600,000 | -31.4% | 3,000,000 | 0.0% | 0.15% | +6.3% | |
| GRPH | GRAPHITE BIO INC | $3,570,000 | -59.0% | 700,000 | 0.0% | 0.15% | -36.9% | |
| LYEL | LYELL IMMUNOPHARMA INC | $3,535,000 | -34.8% | 700,000 | 0.0% | 0.15% | +0.7% | |
| ADAG | ADAGENE INCads | $3,500,000 | -56.6% | 1,000,000 | 0.0% | 0.15% | -32.9% | |
| VOR | VOR BIOPHARMA INC | $3,322,000 | -48.0% | 550,000 | 0.0% | 0.14% | -19.7% | |
| SANA | SANA BIOTECHNOLOGY INC | $3,304,000 | -46.6% | 400,000 | 0.0% | 0.14% | -17.9% | |
| RXRX | Buy | RECURSION PHARMACEUTICALS INcl a | $3,222,000 | -6.0% | 450,000 | +125.0% | 0.14% | +45.2% |
| XILIO THERAPEUTICS INC | $3,182,000 | -55.8% | 450,000 | 0.0% | 0.13% | -31.8% | ||
| CRIS | CURIS INC | $3,094,000 | -50.0% | 1,300,000 | 0.0% | 0.13% | -22.6% | |
| CYCN | CYCLERION THERAPEUTICS INC | $3,085,000 | -35.5% | 2,779,122 | 0.0% | 0.13% | -0.8% | |
| GRTS | GRITSTONE BIO INC | $3,090,000 | -68.0% | 750,000 | 0.0% | 0.13% | -50.8% | |
| ZYME | ZYMEWORKS INC | $2,948,000 | -60.0% | 450,000 | 0.0% | 0.12% | -38.5% | |
| IMMP | IMMUTEP LTDsponsored ads | $2,740,000 | -16.5% | 1,000,000 | 0.0% | 0.12% | +29.2% | |
| CGEM | CULLINAN ONCOLOGY INC | $2,618,000 | -32.1% | 250,000 | 0.0% | 0.11% | +4.8% | |
| YI | 111 INCads | $2,570,000 | -24.0% | 966,349 | 0.0% | 0.11% | +17.4% | |
| BBIO | BRIDGEBIO PHARMA INC | $2,538,000 | -39.1% | 250,000 | 0.0% | 0.11% | -6.2% | |
| ARAV | ARAVIVE INC | $2,531,000 | -11.9% | 1,311,291 | 0.0% | 0.11% | +35.9% | |
| ME | 23ANDME HOLDING CO | $2,532,000 | -42.5% | 661,009 | 0.0% | 0.11% | -10.9% | |
| ORIC | ORIC PHARMACEUTICALS INC | $2,136,000 | -63.7% | 400,000 | 0.0% | 0.09% | -44.4% | |
| TCRR | TCR2 THERAPEUTICS INC | $2,070,000 | -40.8% | 750,000 | 0.0% | 0.09% | -8.4% | |
| WVE | WAVE LIFE SCIENCES LTD | $2,000,000 | -36.3% | 1,000,000 | 0.0% | 0.08% | -1.2% | |
| CRDF | CARDIFF ONCOLOGY INC | $1,860,000 | -58.7% | 750,000 | 0.0% | 0.08% | -36.1% | |
| AXLA | AXCELLA HEALTH INC | $1,831,000 | +23.0% | 712,500 | 0.0% | 0.08% | +92.5% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $1,680,000 | -30.0% | 1,500,000 | 0.0% | 0.07% | +7.7% | |
| KNTE | KINNATE BIOPHARMA INC | $1,408,000 | -36.4% | 125,000 | 0.0% | 0.06% | -1.7% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,390,000 | +7.8% | 110,532 | 0.0% | 0.06% | +65.7% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $1,284,000 | -46.1% | 1,803,858 | 0.0% | 0.05% | -16.9% | |
| CDAK | CODIAK BIOSCIENCES INC | $1,254,000 | -43.7% | 200,000 | 0.0% | 0.05% | -11.7% | |
| HIPPO HLDGS INC | $1,194,000 | -29.7% | 600,000 | 0.0% | 0.05% | +8.7% | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $1,110,000 | -54.5% | 260,500 | 0.0% | 0.05% | -30.3% | |
| XP | New | XP INCcl a | $1,054,000 | – | 35,000 | +100.0% | 0.04% | – |
| Sell | CARIBOU BIOSCIENCES INC | $967,000 | -84.2% | 105,347 | -74.0% | 0.04% | -75.9% | |
| New | AMYLYX PHARMACEUTICALS INC | $964,000 | – | 75,000 | +100.0% | 0.04% | – | |
| LVTX | LAVA THERAPEUTICS NV | $880,000 | -20.0% | 200,000 | 0.0% | 0.04% | +23.3% | |
| KLDO | KALEIDO BIOSCIENCES INC | $826,000 | -30.9% | 500,500 | 0.0% | 0.04% | +9.4% | |
| APLT | APPLIED THERAPEUTICS INC | $844,000 | -76.4% | 400,000 | 0.0% | 0.04% | -63.9% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $820,000 | -32.0% | 500,000 | 0.0% | 0.03% | +3.0% | |
| MINK THERAPEUTICS INC | $652,000 | -49.5% | 289,588 | 0.0% | 0.03% | -22.9% | ||
| MEIP | MEI PHARMA INC | $603,000 | -77.4% | 1,000,000 | 0.0% | 0.02% | -65.3% | |
| MTCR | METACRINE INC | $564,000 | -9.6% | 924,898 | 0.0% | 0.02% | +41.2% | |
| SGTX | SIGILON THERAPEUTICS INC | $406,000 | -46.7% | 276,000 | 0.0% | 0.02% | -19.0% | |
| YMTX | YUMANITY THERAPEUTICS INC | $326,000 | -49.3% | 217,391 | 0.0% | 0.01% | -17.6% | |
| ASTRIA THERAPEUTICS INC | $224,000 | +24.4% | 33,333 | 0.0% | 0.01% | +80.0% | ||
| New | GINKGO BIOWORKS HOLDINGS INC | $202,000 | – | 50,000 | +100.0% | 0.01% | – | |
| CDTX | CIDARA THERAPEUTICS INC | $187,000 | -34.4% | 224,675 | 0.0% | 0.01% | 0.0% | |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| DLO | Exit | DLOCAL LTD | $0 | – | -20,000 | -100.0% | -0.02% | – |
| Exit | RIVIAN AUTOMOTIVE INC | $0 | – | -7,000 | -100.0% | -0.02% | – | |
| MBII | Exit | MARRONE BIO INNOVATIONS INC | $0 | – | -1,048,679 | -100.0% | -0.02% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -321,100 | -100.0% | -0.02% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -100,000 | -100.0% | -0.03% | – |
| AMYT | Exit | AMRYT PHARMA PLCsponsored ads | $0 | – | -150,480 | -100.0% | -0.04% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -180,500 | -100.0% | -0.08% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.11% | – |
| IQ | Exit | IQIYI INCsponsored ads | $0 | – | -1,000,000 | -100.0% | -0.12% | – |
| GDS | Exit | GDS HLDGS LTDsponsored ads | $0 | – | -100,000 | -100.0% | -0.13% | – |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -1,045,000 | -100.0% | -0.14% | – |
| EVLO | Exit | EVELO BIOSCIENCES INC | $0 | – | -1,000,000 | -100.0% | -0.16% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -250,000 | -100.0% | -0.32% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -600,000 | -100.0% | -0.38% | – |
| NG | Exit | NOVAGOLD RES INC | $0 | – | -2,600,000 | -100.0% | -0.48% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.60% | – |
| C | Exit | CITIGROUP INCcall | $0 | – | -1,000,000 | -100.0% | -1.64% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -1,000,000 | -100.0% | -1.69% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -1,000,000 | -100.0% | -3.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.